329 related articles for article (PubMed ID: 16125443)
1. Recent highlights in the development of new antiviral drugs.
De Clercq E
Curr Opin Microbiol; 2005 Oct; 8(5):552-60. PubMed ID: 16125443
[TBL] [Abstract][Full Text] [Related]
2. Antivirals: past, present and future.
De Clercq E
Biochem Pharmacol; 2013 Mar; 85(6):727-44. PubMed ID: 23270991
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in antiviral nucleoside and nucleotide therapeutics.
Simons C; Wu Q; Htar TT
Curr Top Med Chem; 2005; 5(13):1191-203. PubMed ID: 16305526
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy: old and current issues.
Antonelli G; Turriziani O
Int J Antimicrob Agents; 2012 Aug; 40(2):95-102. PubMed ID: 22727532
[TBL] [Abstract][Full Text] [Related]
5. Human viral diseases: what is next for antiviral drug discovery?
De Clercq E
Curr Opin Virol; 2012 Oct; 2(5):572-9. PubMed ID: 22846888
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive review on the antiviral activities of chalcones.
Elkhalifa D; Al-Hashimi I; Al Moustafa AE; Khalil A
J Drug Target; 2021 Apr; 29(4):403-419. PubMed ID: 33232192
[TBL] [Abstract][Full Text] [Related]
7. Looking back in 2009 at the dawning of antiviral therapy now 50 years ago an historical perspective.
De Clercq E
Adv Virus Res; 2009; 73():1-53. PubMed ID: 19695380
[TBL] [Abstract][Full Text] [Related]
8. Clinical use of antiviral drugs.
Nahata MC
Drug Intell Clin Pharm; 1987 May; 21(5):399-405. PubMed ID: 3556126
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy in patients with hematologic malignancies, transplantation, and aplastic anemia.
Jancel T; Penzak SR
Semin Hematol; 2009 Jul; 46(3):230-47. PubMed ID: 19549576
[TBL] [Abstract][Full Text] [Related]
10. Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge.
De Clercq E
Biochem Pharmacol; 2007 Apr; 73(7):911-22. PubMed ID: 17045247
[TBL] [Abstract][Full Text] [Related]
11. A cutting-edge view on the current state of antiviral drug development.
De Clercq E
Med Res Rev; 2013 Nov; 33(6):1249-77. PubMed ID: 23495004
[TBL] [Abstract][Full Text] [Related]
12. Antiviral drugs: current state of the art.
De Clercq E
J Clin Virol; 2001 Aug; 22(1):73-89. PubMed ID: 11418355
[TBL] [Abstract][Full Text] [Related]
13. Emerging antiviral drugs.
De Clercq E
Expert Opin Emerg Drugs; 2008 Sep; 13(3):393-416. PubMed ID: 18764719
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy: current options and challenges.
Reusser P
Schweiz Med Wochenschr; 2000 Jan; 130(4):101-12. PubMed ID: 10780051
[TBL] [Abstract][Full Text] [Related]
15. Current non-AIDS antiviral chemotherapy.
Rottinghaus ST; Whitley RJ
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):217-30. PubMed ID: 17402837
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
17. [Antiviral chemotherapy].
Eggers HJ
Monatsschr Kinderheilkd; 1986 Mar; 134(3):122-9. PubMed ID: 3010086
[TBL] [Abstract][Full Text] [Related]
18. Oral viral infections and the therapeutic use of antiviral agents in dentistry.
McCullough MJ; Savage NW
Aust Dent J; 2005 Dec; 50(4 Suppl 2):S31-5. PubMed ID: 16416715
[TBL] [Abstract][Full Text] [Related]
19. Antiviral agents for non-human immunodeficiency virus infections.
Keating MR
Mayo Clin Proc; 1999 Dec; 74(12):1266-83. PubMed ID: 10593357
[TBL] [Abstract][Full Text] [Related]
20. [The emergence of viruses resistant to antiviral agents: a new challenge].
Boivin G
Union Med Can; 1993; 122(1):31-6. PubMed ID: 8465473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
